ASX Share rice
Thu 06 May 2021 - 08:05:am (Sydney)

EMD Share Price

EMERALD CLINICS LIMITEDEMDHealth Care Equipment & Services

EMD Company Information

Name:

Emyria Limited

Sector:

Healthcare

Industry:

Health Information Services

Address:

43 Oxford Close West Leederville WA Australia 6901

Phone:

1300 436 363

Exec. Chairman:

Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D.

MD & Director:

Dr. Michael Winlo

Chief Financial Officer:

Ms. Su-Mei Sain

Chief Operating Officer:

Mr. Adam James

Exec. Medical Director & Director:

Dr. Alistair Vickery

Company Sec.:

Mr. Simon Robertson C.A., B.Bus, M Appl. Fin, CA

Company Overview:

Emyria Limited, a healthcare technology and services company, operates a network of specialist medical clinics. Its medical clinics offer treatments, such as cannabinoid-based medicines. As of July 31, 2020, the company operated four patient-focused medical clinics. It has a partnership agreement with Mind Medicine Australia to co-develop a gold-standard and data-driven clinical model for the safe provision of psychedelic-assisted therapies in Australia; and a collaboration agreement with Cann Group Limited to register CBD product as a schedule 3 medicine that would result in an over-the-counter, pharmacist-only CBD medicine. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is based in West Leederville, Australia.

EMD Share Price Information

Shares Issued:

254.09M

Market Capitalisation:

$63.52M

Revenue (TTM):

$1.73M

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.0309

Profit Margin:

-2.9928

Operating Margin (TTM):

$-2.51

Return On Assets (TTM):

$-0.61

Return On Equity (TTM):

$-2.82

Quarterly Revenue Growth (YOY):

1.649

Gross Profit(TTM):

$-925,025

Diluted Earnings Per Share (TTM):

$-0.025

EMD CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-201,806

Change To Liabilities:

$243.49K

Total Cashflow From Investing Activities:

$-201,806

Net Borrowings:

$24.84K

Net Income:

$-5,238,040

Total Cash From Operating Activities:

$-4,452,471

Depreciation:

$381.35K

Change To Account Receivables:

$-61,732

Sale Purchase Of Stock:

$6.50M

Capital Expenditures:

$201.81K

EMD Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-5,238,040

Net Income:

$-5,238,040

Gross Profit:

$-925,030

Operating Income:

$-5,238,040

Interest Expense:

$34.50K

Total Revenue:

$1.01M

Cost Of Revenue:

$1.94M

EMD Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$147.31K

Total Liabilities:

$1.28M

Total Stockholder Equity:

$3.78M

Total Assets:

$5.06M

Common Stock:

$11.75M

Other Current Assets:

$24.26K

Retained Earnings:

$-8,053,099

Other Liabilities:

$68K

Other Assets:

$156.56K

Cash:

$3.69M

Total Current Liabilities:

$1M

Short-Term Debt:

$247.15K

Property - Plant & Equipment:

$0.92M

Net Tangible Assets:

$3.64M

Total Current Assets:

$3.84M

Net Receivables:

$97.36K

Short-Term Investments:

$1.23M

Accounts Payable:

$149.05K

Non Currrent Assets (Other):

$156.56K

Short-Term Investments:

$1.23

Non Current Liabilities Total:

$278.97K

EMD Share Price History

EMD News

25 Feb, 2021
We can readily understand why investors are attracted to unprofitable companies. For example, although...
17 Nov, 2020
Whilst it may not be a huge deal, we thought it was good to see that the Emyria Limited (ASX:EMD) Executive Chairman...